DAY 1

19/11/19

BUSINESS PILLAR

12:00 – 12:10

Introduction

Deepak Anand, Chairperson, Medcann World Forum

12:10 – 12:20

Opening keynote speech

Dr. Miriam Dalli, Member of the European Parliament

12:20 – 12:30

Latest Developments from Hoshi International

John B. Aird, CEO, Hoshi

12:30 – 13:00

The Launch of EUMCA

Sita Schubert, General Secretary, EUMCA

12:45 – 13:00

Is Canada still at the forefront of the industry?

John B. Aird, Michael Garbuz, Barinder S. Bhullar, Joel Sherlock, Jeanette VanderMarel

Moderated by Deepak Anand

13:00 – 14:30

LUNCH BREAK

14:30 – 14:45

European legal regulatory environment

Nick Davis, CEO, Memory Crystal

14:45 – 15:00

Zenabis: Next Steps to Medicinal Cannabis and European Market Entry

Andrew Grieve, CEO, Zenabis

15:00 – 15:15

Emmac Life Science: The Latest Developments

Antonio Costanzo, CEO, Emmac Life Science

15:15 – 15:30

Lessons learned from Canadian Legalisation | Policy considerations for safe, accessible, legal medical cannabis

Andrea Paine, National Director of Government Relations, Aurora Cannabis

15:30 – 16:00

Medical Cannabis in Germany – What is next after the tender?

Hendrik Knopp, Managing Director, Aphria Germany

16:00 – 16:45

The Power of Women in Medical Cannabis

Sita Schubert, Luana Mifsud Buhagiar, Rikke Jacobsen, Cheryl Shuman, Jeanette VanderMarel, Marion Zammit

Moderated by Deepak Anand

16:45 – 17:00

Keynote

Kurt Farrugia CEO, Malta Enterprise

17:00 – 17:15

Keynote

Dr. Joseph Muscat, Prime Minister, Malta

17:15 – 17:30

Keynote

Dr. Chris Cardona, Minister for Economy, Investment and Small Businesses

17:30 – 17:40

Keynote

Dr. Deo Debastista, Parliamentary Secretary responsible for Malta Medicines Authority

17:40 – 17:50

Bringing Medicine to the Masses. MGC Pharma as a test case for future phytomedicine development

Ron Lipsky, Co-Founder & Managing Director, MGC Pharmaceuticals

__________________________________________________________

DAY 2

20/11/19

MEDICAL CANNABIS WORLDWIDE, LEGISLATION, TECHNOLOGY & INNOVATION PILLAR

DAY 2 WILL BE MODERATED BY DEEPAK ANAND

10:00 – 10:15

What Business Needs to Learn – Cannabis is A Political Play

Steve Moore, Strategic Counsel, Centre for Medicinal Cannabis

10:15 – 10:30

Planting the seed, a year on

George Gregory, Head of Tax Advisory, RSM Malta moderated Crystal Carson

10:30 – 10:45

The medical policy path to legalization

Chuck Rifici, Founder and CEO, Nesta Holding Co.

10:45 – 11:00

Personal Branding and why it’s the key to all successful ventures.

Cheryl Shuman, Investor, Entrepreneur, Media Personality, Cancer Survivor

11:00 – 11:15

Making patients lives easier – How smart Cannabis Regulation allows access to Medical Cannabis

Fred Cyrus Roeder, Managing Director, Consumer Choice Center

11:15 – 11:30

Investment in Cannabis in Europe

Alex Brooks, Head of European cannabis research, Canaccord Genuity

11:30 – 11:45

The surging Global CBD market- closing the chasm between science and the CBD molecule with real-life evidence

Rick Brar, CEO & Chairman, Brains Bioceutical Cor.

11:45 – 12:00

Danish experience

Rikke Jakobsen, CEO, Cannabis Danmark

12:00 – 12:15

MJBizCon and the value of collaborative approaches to development and knowledge share in global markets

Christopher Day, Vice President of External Relations, Marijuana Business Daily

TECHNOLOGY AND INNOVATION

12:15 – 12:30

More than Manufacturing

Joel Sherlock, Co-Founder & Chairman, Vitalis

12:30 – 12:45

Utilisation of LED Lighting Solutions for Quality Assurance in Medical Cannabis

Timo Bongartz, General Manager, Fluence Bioengineering

12:45 – 13:00

Cannabis Meet Commerce

Jarett Lalonde, Policy Advisor, Regulated Industries, Shopify Plus

13:00 – 14:45

LUNCH BREAK

INDUSTRY INSIGHTS

14:45 – 15:10

From Montevideo to Basel: Key Developments in LatAm and Europe

Alfredo Pascual, International Analyst, Marijuana Business Daily & Nick Pateras, Managing Director, Europe, Materia

15:10 – 15:30

GMP conform drying technology in the Medicinal Cannabis industry

Jochen Schumacher, Technical Sales, Harter Drying Solutions & Jessica Grote, Project Consultant, J&K Consulting

15:30 – 15:50

Colombia and Malta, a cannabis formula for a win-win situation.

Julian Wilches, Chief Regulatory Officer & CoFounder, Clever Leaves

15:50 – 16:10

What my patients taught me about medical cannabis

Dr. Andrew Agius, Medical Director, MD, MSc, PGC

16:10 – 16:25

The Pros & Cons of Investing in The European Cannabis Industry

Stephen Murphy, Managing Director & Co-Founder, Prohibition Partners

16:25 – 16:45

Practical Breeding

Gilad Livni, Chief Genetics Officer, CPTM

16:45 – 16:55

Human Capital: The Costs of Operating Your Cannabis Business

Alison McMahon, Founder & CEO, Cannabis At Work

16:55 – 17:10

Innovation, creativity and vision: Vassallo Business Park’s journey towards the future

Keith Demicoli, Vassallo Group

17:10 – 17:25

Jorja’s Journey with Medical Cannabis

Robin Emerson, Jorja’s Father

__________________________________________________________

DAY 3

21/11/19

EXPECT THE LATEST IN TERMS OF MEDICAL, RESEARCH & EDUCATION

10:00 – 10:10

Introduction to Day 3 of the Med Cann World Forum

Deepak Anand, Chairperson, Medcann World Forum

10:10 – 10:30

Medicinal cannabis: reflections on developments in education and research

Prof Lilian Azzopardi, Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta

10:30 – 10:50

A contribution on the analytical aspects of cannabis

Profs Bruno Botta, Department of Drug Chemistry and Technologies, Sapienza University, Rome

10:50 – 11:10

CBD: consequences beyond disease

Prof Frank Paloucek, Department of Pharmacy Practice, University of Illinois, Chicago

11:10 – 11:30

The world’s first prescription cannabis market – 4 years on

Rhys Cohen, Principal Consultant, FreshLeaf Analytics

11:30 – 12:10

Evidence-based medicine: what is missing in cannabis treatments?

Dr. Orna Dreazen, The chair of Nextage Cannabis Innovation Ltd

12:10 – 12:30

Controversies on cannabis for medicinal use

Prof Anthony Serracino Inglott, Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta

12:30 – 12:50

Legal framework for prescribing medicinal cannabis in Malta

Prof Charmaine Gauci, Superintendence of Public Health, Ministry for Health, Malta

12:50 – 13:10

Malta’s regulatory science landscape: cannabis for medicinal and research purpose

Dr. Luana Mifsud Buhagiar, Advanced Scientific Initiatives Directorate, Malta

13:10 – 13:30

Medicines Authority Cultivation of medicinal cannabis under GACP

Prof Everaldo Attard, Rural Sciences & Food Systems, Institute of Earth Systems, University of Malta

13:30 – 15:15

LUNCH BREAK

INSIGHTS FROM INDUSTRY, CLINICAL AND PATIENT PERSPECTIVES

15:15 – 15:30

Standardization, harmonisation and science in herbal Medicinal Cannabis

Tjalling Erklens, CEO, Bedrocan

15:30 – 15:45

Understanding Medical Cannabis

Gregor Zorn, Co-Founder, European Cannabinoid Therapy Association

15:45 – 16:00

Neural networks; A glimpse into cannabis intelligence

Dr. Zeid Mohamedali, Chief Medical Officer, Zenabis

16:00 – 16:15

How Canada defined GPP and the migration to GMP. Interpretation of the Eudralex at to when GACP gets converted to GMP.

Robert Picard, Interim Vice-President Technical Services and QA, Aphria Inc.

16:15 – 16:30

A cancer patient survivor

Cheryl Shuman, Investor, Entrepreneur, Media Personality, Cancer Survivor

16:30 – 16:45

Towards evidence-based cannabinoid medicine: the German experience

Jan Witte M.D, Medical Director, Aphria Germany

16:45 – 17:00

Cannabis and Science

Lucas McCann, Chief Scientific Officer, Canndelta

17:00 – CLOSE

Conclusion

Deepak Anand